Abstract:A retrospective study on screening methods for fetal trisomy 18 has been carried out in two different laboratories using the serum parameters: total human chorionic gonadotropin (hCG), unconjugated oestriol (uE3), and alpha-fetoprotein (AFP) in different combinations and in single marker protocols. Laboratory A (L(A)) utilized a radio-immunoassay to examine 38 fetal trisomy 18 cases and laboratory B (L(B)) utilized an enzyme-immunoassay to examine 33 trisomy 18 cases. As unaffected references the whole routine cohorts of each laboratory were used (L(A): 29 043; L(B): 4264). In both trisomy 18 study groups the median hCG and uE3 multiples of the median (MoM) values were markedly declined (L(A): 0.21 MoM, 0.37 MoM; L(B): 0.31 MoM, 0.44 MoM). Even after exclusion of trisomy 18 cases with combined neural tube or ventral wall defects the medians of AFP MoM values were only moderately declined (L(A): 0.73 MoM; L(B): 0.8 MoM). Receiver-operator characteristic (ROC) curves after multivariate discriminance analysis and single marker evaluation demonstrated that the difference of efficiency between a combination of hCG, uE3 and AFP, and a combination of hCG and uE3 is small but that any of these combinations are more efficient than a combination of hCG and AFP or single marker protocols, respectively. At a risk cut-off generating a false-positive rate of one per cent the most effective marker combination detected 31 of 38 (81.6 per cent) affected pregnancies in L(A) and 25 of 33 (75.8 per cent) in L(B). The differences in sensitivity and specificity seem to be due to the different analytical systems being utilized by the two laboratories.

EP18.38: Double serological test values in first trimester screening in spontaneous pregnancies versus assisted reproduction techniques

EP18.07: Repeat cell‐free DNA testing in the third trimester after discordant high‐risk results

EP17.23: The connection between first trimester biochemical screening results and the risk of neonatal complications post‐delivery

A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratories

EP18.05: First trimester referral ultrasound following the introduction of the guidelines of the SIEOG: focus on false positives and false negatives

EP17.09: Performance of sFlt1 ‐PlGF ratio at 35–36 weeks of gestation in nulliparous women in identifying SGA, pre‐eclampsia and FGR

EP18.29: First trimester screening at conditions of limited resources

EP17.42: Association between mean arterial pressure and uterine artery pulsatility index >95th percentile in first trimester screening in singleton pregnancies

EP08.17: Variations in first trimester fetal growth in pregnancies conceived by assisted reproductive technology

OC06.07: Cost‐effectiveness of the prenatal screening algorithm for the detection of trisomies in patients with intermediate risk

EP08.03: First trimester fetal size in pregnancies conceived by assisted reproductive technology compared to reference curves

EP17.15: Evaluation of clinical and biophysical markers as a screening test for late‐onset pre‐eclampsia between 35 and 38 weeks of gestation

EP17.63: Association between body mass index and mean uterine artery pulsatility index >95th percentile in first trimester singleton pregnancies screening

EP17.07: Comparison of different methods of screening for preterm pre‐eclampsia

Serial first- and second-trimester Down's syndrome screening tests among IVF-versus naturally-conceived singletons

EP14.23: Ultrasound screening for preterm birth in twin pregnancies: a prospective longitudinal pilot study

EP01.12: AI demonstrates high detection in first trimester screening for spina bifida

EP18.47: Reconfirm prenatal 22q11.2 duplication syndrome with different non‐invasive prenatal testing method: a two‐case study

EP14.13: Anastomosis placentarias en embarazos gemelares monocoriónicos: estudio mediante técnicas de inyección vascular y relación con complicaciones fetales

EP18.18: Development of a multivariate predictive model for Trisomy 21 risk assessment at 20–25 weeks of gestation

Analysis of triple test results in 27 cases of twin pregnancies